Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of the Interaction Network of Hub Genes in the Progression of Barrett's Esophagus to Esophageal Adenocarcinoma. | J Inflamm Res | 2023 | 37077220 | PubTator, text mining | PubMed |
| Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression. | Cancer Res | 2023 | 37062029 | PubTator, text mining | PubMed |
| Expansion and characterization of human limbus-derived stromal/mesenchymal stem cells in xeno-free medium for therapeutic applications. | Stem Cell Res Ther | 2023 | 37061739 | PubTator, text mining | PubMed |
| A perspective on recent findings and future strategies for reactive aldehyde removal in spinal cord injury. | Neural Regen Res | 2023 | 37056131 | PubTator, text mining | PubMed |
| Advances in the study of regulators of ferroptosis in head and neck squamous cell carcinoma (Review). | Int J Mol Med | 2023 | 37052257 | PubTator, text mining | PubMed |
| Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma. | Cancer Sci | 2023 | 37026527 | PubTator, text mining | PubMed |
| Tear proteomics in dry eye disease. | Indian J Ophthalmol | 2023 | 37026251 | PubTator, text mining | PubMed |
| Identification of a peptide ligand for human ALDH3A1 through peptide phage display: Prediction and characterization of protein interaction sites and inhibition of ALDH3A1 enzymatic activity. | Front Mol Biosci | 2023 | 37021113 | PubTator, text mining | PubMed |
| Investigating the Functional Roles of Aldehyde Dehydrogenase 3A1 in Human Corneal Epithelial Cells. | Int J Mol Sci | 2023 | 36982917 | PubTator, text mining | PubMed |
| In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin. | Curr Issues Mol Biol | 2023 | 36975509 | PubTator, text mining | PubMed |
| State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer. | Front Oncol | 2023 | 36969009 | PubTator, text mining | PubMed |
| Characterization of human oxidoreductases involved in aldehyde odorant metabolism. | Sci Rep | 2023 | 36966166 | Swiss-Prot, curated | PubMed |
| Discovery of novel glioma serum biomarkers by proximity extension assay. | Clin Proteomics | 2023 | 36959545 | PubTator, text mining | PubMed |
| Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs. | Redox Biol | 2023 | 36958250 | PubTator, text mining | PubMed |
| Construction of a fatty acid metabolism-related gene signature for predicting prognosis and immune response in breast cancer. | Front Genet | 2023 | 36936412 | PubTator, text mining | PubMed |
| NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice. | Front Immunol | 2023 | 36911699 | PubTator, text mining | PubMed |
| Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer. | Mol Ther Nucleic Acids | 2023 | 36910711 | PubTator, text mining | PubMed |
| Pinostrobin from plants and propolis against human coronavirus HCoV-OC43 by modulating host AHR/CYP1A1 pathway and lipid metabolism. | Antiviral Res | 2023 | 36863496 | PubTator, text mining | PubMed |
| Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts. | J Cancer | 2023 | 36860923 | PubTator, text mining | PubMed |
| Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database. | Chin Med Sci J | 2023 | 36855320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=10